1.
Matrix-insensitive protein assays push the limits of biosensors in medicine
by Gambhir, Sanjiv S
Nature medicine, 2009-11, Vol.15 (11), p.1327-1332
2.
Tumor grafts derived from sarcoma patients retain tumor morphology, viability, and invasion potential and indicate disease outcomes in the chick chorioallantoic membrane model
by Sys, Gwen
Cancer letters, 2012, Vol.326 (1), p.69-78
3.
Murine xenograft model demonstrates significant radio-sensitising effect of liposomal doxorubicin in a combination therapy for Feline Injection Site Sarcoma
by Petznek, H
Research in veterinary science, 2014-10, Vol.97 (2), p.386-390
4.
Mesenchymal Stem Cells as Therapeutic Delivery Vehicles Targeting Tumor Stroma
by Serakinci, Nedime
Cancer biotherapy & radiopharmaceuticals, 2011-12-01, Vol.26 (6), p.767-773
5.
Human primary liver cancer-derived organoid cultures for disease modeling and drug screening
by Broutier, L
Nature medicine, 2017, Vol.23 (12), p.1424-+
6.
A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo
by Li, Suping
Nature biotechnology, 2018-03, Vol.36 (3), p.258-264
7.
Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M + diffuse midline gliomas
by Mount, Christopher W
Nature medicine, 2018-05, Vol.24 (5), p.572-579
8.
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
by Souers, Andrew J
Nature medicine, 2013-02, Vol.19 (2), p.202-208
9.
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
by Gao, Hui
Nature medicine, 2015-11, Vol.21 (11), p.1318-1325
10.
Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
by Baccelli, Irène
Nature biotechnology, 2013-06, Vol.31 (6), p.539-544
11.
An inhibitor of oxidative phosphorylation exploits cancer vulnerability
by Molina, Jennifer R
Nature medicine, 2018-07, Vol.24 (7), p.1036-1046
12.
Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers
by Kinsey, Conan G
Nature medicine, 2019-04, Vol.25 (4), p.620-627
13.
CD47 blockade triggers T cell-mediated destruction of immunogenic tumors
by Liu, Xiaojuan
Nature medicine, 2015-10, Vol.21 (10), p.1209-1215
14.
The cancer stem cell: premises, promises and challenges
by Clevers, H
Nature medicine, 2011, Vol.17 (3), p.313-319
15.
Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates
by Lyon, Robert P
Nature biotechnology, 2014-10, Vol.32 (10), p.1059-1062
16.
In vivo molecular imaging for immunotherapy using ultra-bright near-infrared-IIb rare-earth nanoparticles
by Zhong, Yeteng
Nature biotechnology, 2019-11, Vol.37 (11), p.1322-1331
17.
H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers
by Seiler, Michael
Nature medicine, 2018-05, Vol.24 (4), p.497-504
18.
Bovine milk-derived exosomes for drug delivery
by Munagala, Radha
Cancer letters, 2015, Vol.371 (1), p.48-61
19.
An injectable nanoparticle generator enhances delivery of cancer therapeutics
by Xu, Rong
Nature biotechnology, 2016-04, Vol.34 (4), p.414-418
20.
A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress
by Bruno, Peter M
Nature medicine, 2017-04, Vol.23 (4), p.461-471
